Two Sigma Securities’s Alzamend Neuro ALZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-21
| Closed | -$6.67K | – | 1428 |
|
|
2023
Q3 | $6.67K | Buy |
21
+4
| +24% | +$1.27K | ﹤0.01% | 1220 |
|
|
2023
Q2 | $11.5K | Buy |
17
+4
| +31% | +$2.72K | ﹤0.01% | 1062 |
|
|
2023
Q1 | $7.57K | Sell |
13
-13
| -50% | -$7.57K | ﹤0.01% | 1193 |
|
|
2022
Q4 | $19.8K | Buy |
+26
| New | +$19.8K | ﹤0.01% | 1072 |
|
|
2022
Q3 | – | Sell |
-11
| Closed | -$13K | – | 1345 |
|
|
2022
Q2 | $13K | Sell |
11
-14
| -56% | -$16.5K | ﹤0.01% | 1055 |
|
|
2022
Q1 | $42K | Buy |
25
+2
| +9% | +$3.36K | ﹤0.01% | 900 |
|
|
2021
Q4 | $58K | Buy |
+23
| New | +$58K | ﹤0.01% | 756 |
|
|
2021
Q3 | – | Sell |
-12
| Closed | -$140K | – | 838 |
|
|
2021
Q2 | $140K | Buy |
+12
| New | +$140K | ﹤0.01% | 537 |
|